Artwork

内容由Dean Fanelli and Dr. Dean Fanelli提供。所有播客内容(包括剧集、图形和播客描述)均由 Dean Fanelli and Dr. Dean Fanelli 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

A plan to get the world fully vaccinated

22:26
 
分享
 

Manage episode 319539441 series 2893097
内容由Dean Fanelli and Dr. Dean Fanelli提供。所有播客内容(包括剧集、图形和播客描述)均由 Dean Fanelli and Dr. Dean Fanelli 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

At first glance, it may seem as if the world will soon have more than enough COVID-19 vaccines but Prashant Yadav says over 70 percent of the vaccines produced in 2021 were bought by high- and upper-middle-income countries. Less than one percent, by contrast, have gone to low-income ones. And, he says, it’s not just a problem of aggregate distribution.

“The world may appear to have lots of vaccines, but only 27 percent of them are messenger RNA (mRNA) shots, which train the body to make the protein that allows COVID-19 to infect cells and then the antibodies that fight it off. And so far, these are the vaccines that appear able to prevent people from becoming sick with the new, very contagious Omicron variant. These more effective and adaptable vaccines are even more concentrated in rich states than are shots overall.”

Yadav says the solution is for wealthy countries, multilateral development banks, and global health agencies to expand mRNA manufacturing in regions and countries that have little to no capacity. Prashant Yadav is a senior fellow at the Center for Global Development and affiliate professor of technology and operations management at INSEAD

  continue reading

51集单集

Artwork
icon分享
 
Manage episode 319539441 series 2893097
内容由Dean Fanelli and Dr. Dean Fanelli提供。所有播客内容(包括剧集、图形和播客描述)均由 Dean Fanelli and Dr. Dean Fanelli 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

At first glance, it may seem as if the world will soon have more than enough COVID-19 vaccines but Prashant Yadav says over 70 percent of the vaccines produced in 2021 were bought by high- and upper-middle-income countries. Less than one percent, by contrast, have gone to low-income ones. And, he says, it’s not just a problem of aggregate distribution.

“The world may appear to have lots of vaccines, but only 27 percent of them are messenger RNA (mRNA) shots, which train the body to make the protein that allows COVID-19 to infect cells and then the antibodies that fight it off. And so far, these are the vaccines that appear able to prevent people from becoming sick with the new, very contagious Omicron variant. These more effective and adaptable vaccines are even more concentrated in rich states than are shots overall.”

Yadav says the solution is for wealthy countries, multilateral development banks, and global health agencies to expand mRNA manufacturing in regions and countries that have little to no capacity. Prashant Yadav is a senior fellow at the Center for Global Development and affiliate professor of technology and operations management at INSEAD

  continue reading

51集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南